FAQ on Creative Biolabs' Webinar on Next-Generation Tumoroid-on-a-Chip Technology

What is the main topic of the webinar?

The webinar focuses on the tumoroid-on-a-chip platform, a microfluidic-based 3D tumor model designed to offer more physiologically relevant conditions for preclinical testing.

Why is the tumoroid-on-a-chip technology significant?

This technology is significant because it provides a more representative in vitro environment for solid tumors, enabling more accurate drug response assessments and bridging the gap between laboratory research and clinical practice.

How does the tumoroid-on-a-chip platform work?

The platform incorporates key structural and cellular features of solid tumors into a microfluidic-based 3D model, allowing for the simulation of more physiologically relevant conditions for preclinical testing.

Who is presenting the webinar?

Dr. Mohsen Akbari, an Associate Professor from the University of Victoria and the Director of the Laboratory for Innovations in Microengineering (LiME), is presenting the webinar.

When is the webinar taking place?

The webinar is scheduled for August 22, 2025, at 12:00 PM EDT.

Where can I register for the webinar?

You can register for the webinar by visiting the provided link: Register Now.

What are the key topics to be covered in the webinar?

Key topics include the evolution from multi-compartment tumor chips to high-throughput tumoroid-on-plate systems, strategies to incorporate cellular heterogeneity and ECM complexity, immunotherapy screening under near-physiological conditions, and applications in preclinical drug testing and personalized oncology.

What is Creative Biolabs’ 3D Tumor Modeling Portfolio?

Creative Biolabs offers a comprehensive portfolio of 3D tumor modeling platforms, including Ex Vivo Tissue Models, Precision-Cut Tissue Slicing Models, 3D Spheroid Models, 3D Organoid Models, and Organ-on-a-Chip Models, designed to evaluate drug responses under conditions that better reflect the in vivo tumor microenvironment.

Who should attend this webinar?

Researchers and professionals in oncology, drug development, and related fields would benefit from attending this webinar to explore how microfluidic platforms are revolutionizing cancer research.

How does the tumoroid-on-a-chip compare to conventional 2D cultures?

Unlike conventional 2D cultures, which are limited in replicating tumor complexity, tumoroid-on-a-chip offers a more representative in vitro environment by incorporating key structural and cellular features of solid tumors, allowing for more accurate assessment of drug response.